Pinnacle Financial Partners (PNFP)
NYSEFinancialsBanks - RegionalSnapshot 2026-10-30
NYSEFinancialsBanks - RegionalSnapshot 2026-10-30
Research Workspace
Put PNFP beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Regional Banks is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Primary pillar under pressure — EPS reaches at least $11.63 in fiscal 2027: Diluted EPS: $2.07 per share.
View ThesisRanks in the weakest quality tier of its industry — roughly the bottom 44%, softest on share dilution.
View QualityManagement screens weak on capital allocation, the balance sheet.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationRelatively steady — typically moves about 1% a day.
View RiskPNFP’s case rests on strong financial performance, robust cash-backed earnings, and modest price expectations. Revenue grew year over year in Q2, while non-GAAP EPS rose across three reported quarters. Q3 2026 non-GAAP EPS beat consensus by 3.1%. PNFP trades at 1× P/B versus a 1.2× peer median and its 1.1× historical multiple. The price reflects less growth than our forecast, though the fiscal 2027 EPS pillar is under pressure. Our model puts the next-quarter miss probability near 18%. Peer multiples imply a price about 13% above where it trades; the thesis is on watch. This read is provisional.
Trailing returns as of 2026-10-30. PNFP is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 22 analysts currently covering PNFP (as of Oct 2026).
Based on 14 Wall Street analysts offering 12-month price targets for PNFP in the last 4 months.
Continue this research
Compare PNFP with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| PNFP Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 9 valuation methods, at three horizons. As of 2026-10-30. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Regional Banks — fair value, gap to price, and forward P/E.
Compare the value case
Put PNFP next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Complete integration and growth post-Synovus merger
Broad-based loan growth supports post-merger integration and growth.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-10-30. EPS is implied from price ÷ P/E. Not investment advice.
Current $101.66
The last 12 months of price, then the range of analyst 12-month targets from today’s $101.66.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Below average on quality vs scored peers
Advances: Complete integration and growth post-Synovus merger
Leadership extension and dividend raise signal confidence in post-merger growth.
Missed sales expectations may hinder growth objectives.
Advances: Issue $750M in Senior Notes
Successful notes offering supports capital allocation objective.
Advances: Complete Merger with Synovus
SWOT analysis indicates growth potential post-merger.